ライフサイエンスコーパス: directly observed therapy

1 antituberculosis therapy using intermittent directly observed therapy.

2 sis, confirming the efficacy of intermittent directly observed therapy.

3 ended by the World Health Organization under directly observed therapy.

4 11-5.43) were less likely to receive IPTp by directly observed therapy.

5 ecause of improved access to health care and directly observed therapy.

6 onadherence and should have been assigned to directly observed therapy.

7 coadministered with methadone using modified directly observed therapy.

8 otal of 150 patients were ordered to undergo directly observed therapy, 139 patients to be detained d

9 zithromycin (AZ) or placebo, administered as directly observed therapy 4 times per year between Augus

10 Directly observed therapy also appears to be cost-effect

11 trol measures in the homeless should include directly observed therapy and incentive approaches, trea

12 Additional innovative models include directly observed therapy and peer-based models.

13 initiation, previous tuberculosis treatment, directly observed therapy, and acid-fast-bacilli smear-p

14 rvised strategies and modified approaches to directly observed therapy, are unlikely to achieve this

15 Patients treated by directly observed therapy at the start of therapy (n = 1

16 This study shows that in a directly observed therapy-based MDR tuberculosis program

17 Eight-day inpatient directly observed therapy confirmed nonadherence as the

18 Directly observed therapy coverage increased from 74% to

19 erence to medication in persons using WOT or directly observed therapy (DOT) during TB treatment.

20 model to estimate the cost-effectiveness of directly observed therapy (DOT) for individuals with new

21 The use of directly observed therapy (DOT) for nearly all cases of

22 To determine the incremental cost of directly observed therapy (DOT) for patients with tuberc

23 PrEP was administered to women through daily directly observed therapy (DOT) for ten consecutive days

24 We evaluated the superiority of directly observed therapy (DOT) for tuberculosis patient

25 Electronic directly observed therapy (DOT) is used increasingly as

26 zid and rifapentine (3HP) administered under directly observed therapy (DOT) might increase treatment

27 idual treatment (SIT), group treatment (GT), directly observed therapy (DOT), and no intervention for

28 signed (1:1:1) to receive 3HP by facilitated directly observed therapy (DOT), facilitated self-admini

29 ed strategies for delivering 3HP-facilitated directly observed therapy (DOT), facilitated self-admini

30 eighborhood-specific rates of application of directly observed therapy (DOT).

31 treatment failure/death were the absence of directly observed therapy (DOT; adjusted hazard ratio [a

32 Directly observed therapy (DOTS) is the main strategy fo

33 was compared with 2- and 4-week samples from Directly Observed Therapy Dried Blood Spots (DOT-DBS) St

34 supervision could be a viable alternative to directly observed therapy for a substantial proportion o

35 conclude that treatment plans that emphasize directly observed therapy from the start of therapy have

36 ly assigned 259 participants to the modified directly observed therapy group (n=129) or the standard-

37 34 (26%) participants in the modified directly observed therapy group achieved the primary end

38 was 25.1% (95% CI 17.7-32.4) in the modified directly observed therapy group and 17.3% (10.8-23.7) in

39 laboratory abnormality (n=21 in the modified directly observed therapy group and n=15 in the standard

40 Partner-based training with modified directly observed therapy had no effect on virological s

41 ment, good cooperation between services, and directly observed therapy improved treatment outcome and

42 nd tolerability of 12 weeks of INH/RPT given directly observed therapy in 17 consecutive SOT candidat

43 on receiving some portion of treatment under directly observed therapy increased from 27.3% to 59.1%

44 To improve adherence and cure rates, directly observed therapy is recommended for the treatme

45 randomized trial of a partner-based modified directly observed therapy (mDOT) compared with standard

46 l measures such as uniform implementation of directly observed therapy might reduce the proportion of

47 fference in standard of care versus modified directly observed therapy of -6.6% (95% CI -16.5% to 3.2

48 s were randomly assigned to receive modified directly observed therapy or patient navigation.

49 omisation, to receive partner-based modified directly observed therapy or standard of care.

50 pot urine and plasma samples during a 6-week directly observed therapy period and a 4-week washout pe

51 standardized dosing, which is prescribed in directly observed therapy programs.

52 use of case management strategies (including directly observed therapy), regimen and dosing selection

53 didates, combination INH/RPT weekly given as directly observed therapy seems to be reasonably well to

54 s, driven by the World Health Organization's directly observed therapy, short course strategy.

55 gies to improve treatment adherence, such as directly observed therapy, should be used.

56 Hair strands from volunteers enrolled in a directly observed therapy study were analyzed by IR-MALD

57 966 to August 1, 1996) with original data on directly observed therapy, supervised therapy, complianc

58 n), and high-intensity (patient navigation + directly observed therapy) support, respectively.

59 As compared with patients ordered to receive directly observed therapy, the patients who were detaine

60 003), and cavitary disease in the absence of directly observed therapy throughout therapy (OR, 2.65;

61 e more often, and were less likely to accept directly observed therapy voluntarily.

62 Directly observed therapy was associated with greater ad

63 he proportion of observed doses on days when directly observed therapy was attempted.

64 nd the less restrictive measure of mandatory directly observed therapy was often effective.

65 s based on a patient-centered approach using directly observed therapy with multiple enablers and enh

66 ner-based support intervention with modified directly observed therapy would improve outcomes with se